Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies

Leukemia

Volumn 11, Issue 11, 1997, Pages 1813-1816

  Pui, C H ^a,b   Relling, M V ^a,b   Lascombes, F ^c   Harrison, P L ^a   Struxiano, A ^c   Mondesir, J M ^c   Ribeiro, R C ^a,b   Sandlund, J T ^a,b   Rivera, G K ^a,b   Evans, W E ^a,b   Mahmoud, H H ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c SANOFI   (France)

Author keywords

Acute lymphoblastic leukemia; Hyperuricemia; Tumor lysis syndrome; Urate oxidase; Uric acid

Indexed keywords

CREATININE; MERCAPTOPURINE; METHOTREXATE; URATE OXIDASE; UREA; URIC ACID; URICOZYME;

ACUTE KIDNEY FAILURE; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; B CELL LEUKEMIA; BRONCHOSPASM; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DRUG HYPERSENSITIVITY; DRUG RESPONSE; HUMAN; HYPERURICEMIA; HYPOXEMIA; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL; URTICARIA;

EID: 16944364892     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400850     Document Type: Article

References (27)

1. Rieselbach RE, Bentzel CJ, Cotlove E, Frei E III, Freireich EJ. Uric acid excretion and renal function in the acute hyperuricemia of leukemia: pathogenesis and therapy or uric acid nephropathy. Am J Med 1964; 37: 872-884.
2. Holland P, Holland NH. Prevention and management of acute hyperuricemia in childhood leukemia. J Pediatr 1968; 72: 358-366.
3. Krakoff IH, Murphy ML. Hyperuricemia in neoplastic disease in children: prevention with allopurinol, a xanthine oxidase inhibitor. Pediatrics 1968; 41: 52-56.
4. Jones DP, Mahmoud H, Chesney RW. Tumor lysis syndrome: pathogenesis and management. Pediatr Nephrol 1995; 9: 206-212.
5. Cohen LF, Balow JE, Magrath IT, Poplack DG, Ziegler JL. Acute tumor lysis syndrome: a review of 37 patients with Burkitt's lymphoma. Am J Med 1980; 68: 486-491.
6. Jones DP, Stapleton FB, Kalwinsky D, McKay CP, Kellie SJ, Pui CH. Renal dysfunction and hyperuricemia at presentation and relapse of acute lymphoblastic leukemia. Med Pediatr Oncol 1990; 18: 283-286.
7. DeConti RC, Calabresi P. Use of allopurinol for prevention and control of hyperuricemia in patients with neoplastic disease. New Engl J Med 1966; 274: 481-486.
8. Andreoli SP, Clark JH, McGuire WA, Bergstein JM. Purine excretion during tumor lysis in children with actue lymphocytic leukemia receiving allopurinol: relationship to acute renal failure. J Pediatr 1986; 109: 292-298.
9. Klinenbeg JR, Goldfincer SE, Seegmiller JE. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout. Ann Intern Med 1965; 62: 639-647.
10. Greene ML, Fujimoto WY, Seegmiller JE. Urinary xanthine stones - a rare complication of allopurinol therapy. New Engl J Med 1969; 280: 426-427.
11. Band PR, Silverberg DS, Henderson JF, Ulan RA, Wensel RH, Banerjee TK, Little AS. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. New Engl J Med 1970; 283: 354-357.
12. Ablin A, Stephens BG, Hirata T, Wilson K, Williams HE. Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol. Metabolism 1972; 21: 771-778.
13. Shohet I, Aladjem M, Lotan D, Katznelson D, Sperling D, Kende G. Acute renal failure complicating Burkitt's lymphoma treated with chemotherapy and allopurinol. Intl J Pediatr Nephrol 1980; 1: 240-241.
14. Brogard JM, Coumarso D, Franckhauser J, Stahl A, Stahl J. Enzymatic uricolysis: a study of the effect of a fungal urate-oxydase. Rev Eur Etudes Clin Biol 1972; 17: 890-895.
15. Gardais J. L'urate-oxydase dans le traitement des hemopathies malignes. Quest Med 1976; 29: 1199-1203.
16. Robert A, Corberand J, Regnier CL. Utilisation de l'urate-oxydase dans la prevention et le traitement des hyperuricemies dan 20 cas de leucose aigue de l'enfant. Rev Med Toulouse 1976; 12 (Suppl. 6): 1093-1100.
17. Masera G, Jankovic M, Zurlo MG, Locasciulli A, Rossi MR, Uderzo C, Recchia M. Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia. J Pediatr 1982; 100: 152-155.
18. Jankovic M, Zurlo MG, Rossi E, Edefonti A, Cossu MM, Giani M, Masera G. Urate-oxidase as hypouricemic agent in a case of acute tumor lysis syndrome. Am J Pediatr Hematol Oncol 1985; 7: 202-204.
19. Synold TW, Relling MV, Boyett JM, Rivera GK, Sandlund JT, Mahmoud H, Crist WM, Pui C-H, Evans WE. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J Clin Invest 1994; 94: 1996-2001.
20. Masson E, Relling MV, Synold TW, Liu Q, Schuetz JD, Sandlund JT, Pui C-H, Evans WE. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo: a rationale for high-dose methotrexate. J Clin Invest 1996; 97: 73-80.
21. Pui C-H, Rivera GK, Hancock ML, Sandlund JT, Ribeiro RC, Boyett JM, Relling MV, Evans WE, Crist WM. Risk-adapted findings for ALL - from St Jude Children's Research Hospital. In: Buchner T, Hiddemann W, Wörmann B, Schellong G, Ritter J, Creutzig J (eds). Acute Leukemias VI. Prognostic Factors and Treatment Strategies. Haematology and Blood Transfusions. Springer-Verlag: Berlin, Heidelberg, 1997, pp 629-637.
22. Masson E, Synold TW, Relling MV, Schuetz JD, Sandlund JT, Pui C-H, Evans WE. Allopurinol inhibits de novo purine synthesis in lymphoblasts of children with acute lymphoblastic leukemia. Leukemia 1996; 10: 56-60.
23. Patte C, Leverger G, Rubie H, Bertrand Y, Coze C, Méchinaud F, Lutz P, Michon J, Baruchel A, Courbon B for the SFOP. High cure rate in B-cell (Burkitt's) leukemia in the LMB 89 protocol of the SFOP (French Pediatric Oncology Society). Proc ASCO 1993; 12: 317 (Abstr).
24. Pui C-H. Childhood leukemias. New Engl J Med 1995; 332: 1618-1630.
25. Tsokos GC, Balow JE, Spiegel RJ, Magrath IT. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine 1981; 60: 218-229.
26. Stapleton FB, Strother DR, Roy S III, Wyatt RJ, McKay CP, Murphy SB. Acute renal failure at onset of therapy for advanced stage Burkitt lymphoma and B cell acute lymphoblastic lymphoma. Pediatrics 1988; 82: 863-869.
27. Bowman WP, Shuster JJ, Cook B, Griffin T, Behm F, Pullen J, Link M, Head D, Carroll A, Berard C, Murphy S. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group Study. J Clin Oncol 1996; 14: 1252-1261.